Gene prioritisation for enhancing molecular diagnosis in rare skeletal muscle disease cohort
Victoria Lillback(University of Helsinki), Marco Savarese(Folkhälsans Forskningscentrum), Peter Hackman(Folkhälsans Forskningscentrum), Vincenzo Nigro(University of Campania "Luigi Vanvitelli"), Filippo M. Santorelli(Fondazione Stella Maris), Maria Francesca Di Feo(University of Helsinki), Gaber Bergant(Ljubljana University Medical Centre), Bjarne Udd(Folkhälsans Forskningscentrum), Katarina Pelin(University of Helsinki), Annalaura Torella(University of Campania "Luigi Vanvitelli"), Ivana Babič Božović(Ljubljana University Medical Centre), Mridul Johari(University of Helsinki), Borut Peterlin(University of Ljubljana), Aleš Maver(Ljubljana University Medical Centre)
Cited by 1
Related Papers
The myotonic dystrophies: molecular, clinical, and therapeutic challenges
|The Lancet Neurology|2012|487
Tibial Muscular Dystrophy Is a Titinopathy Caused by Mutations in TTN, the Gene Encoding the Giant Skeletal-Muscle Protein Titin
|The American Journal of Human Genetics|2002|484
Mutations in the skeletal muscle α-actin gene in patients with actin myopathy and nemaline myopathy
|Nature Genetics|1999|401
Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy
|Nature Medicine|2011|333
Mutations in the nebulin gene associated with autosomal recessive nemaline myopathy
|Proceedings of the National Academy of Sciences|1999|332